Could blood tests Fine-Tune a major cancer drug?

NCT ID NCT06195527

Recruiting now Disease control Sponsor: University Hospital, Angers Source: ClinicalTrials.gov ↗

Summary

This study aims to see if closely monitoring the amount of a cancer drug (pembrolizumab) in a patient's blood can help doctors use it more effectively. It will involve 75 adults with non-small cell lung cancer who are already receiving this treatment. Researchers will check if specific drug levels are linked to better tumor control and fewer side effects.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Angers University Hospital
RECRUITING

Angers, 49000, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
CH Le Mans
NOT_YET_RECRUITING

Le Mans, 53000, France

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

NON-SMALL CELL LUNG CANCER